Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Histology and Histopathology|November 3, 2023
Atypical meningioma: Histopathological, genetic, and epigenetic features to predict recurrence riskElena Marastoni, Valeria BarresiCancers|June 10, 2023
Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeElena Marastoni, Valeria BarresiCancers|May 11, 2024
Diffuse Gliomas with <i>FGFR3</i>::<i>TACC3</i> Fusion: Morphological and Molecular Features and Classification ChallengesElena Marastoni, Davide Mulone, Valeria BarresiBrain Pathology (Zurich, Switzerland)|July 6, 2023
A diffuse glioma with oligodendroglial-like cells and extensive calcificationsFilippo Maria Martelli, Elena Marastoni, Valeria BarresiVirchows Archiv : an International Journal of Pathology|January 17, 2024
H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfallElena Marastoni, Serena Ammendola, Sabrina Rossi, et al.Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structuresMario Bigioni, Alessandro Ettorre, Patrizia Felicetti, et al.Bioorganic & Medicinal Chemistry Letters|April 22, 2008
E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluationGiuseppe Giannini, Mauro Marzi, Walter Cabri, et al.Journal of Medicinal Chemistry|April 23, 2010
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptorDaniela Fattori, Marina Porcelloni, Piero D'Andrea, et al.Journal of Medicinal Chemistry|August 18, 2006
Synthesis and cytotoxic activity of polyamine analogues of camptothecinSabrina Dallavalle, Giuseppe Giannini, Domenico Alloatti, et al.Bioorganic & Medicinal Chemistry Letters|June 18, 2013
Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 1: hit identificationElena Marastoni, Sandra Bartoli, Marco Berettoni, et al.Pageof 2